A Potential Notion on Alzheimer’s Disease: Nanotechnology as an Alternative Solution

Figure 5

Anatomy of nanocarriers used for Alzheimer’s disease drug delivery across the blood−brain barrier. Dendrimers, polymeric nanoparticles, and liposomes are examples of nanocarriers that have been used to deliver therapeutic agents across the blood−brain barrier for the treatment of Alzheimer’s disease. To cross the blood−brain barrier, studies have shown optimal particle diameters ranging from 5 to 200 nm.